Rob Eerdekens,Mohamed El Farissi,Giovanni Luigi De Maria,Aviel Shetrit,Robert Sykes,Christina Ekenbäck,Jonas Persson,Jonas Spaak,Liam S Couch,Fernando Alfonso,Fernando Rivero,Nieves Gonzalo,Javier Escaned,Iván J Núñez Gil,Oscar Vedia Cruz,Reut Amar Shamir,Ophir Freund,Marc Vanderheyden,Marta Belmonte,Emanuele Barbato,Pim A L Tonino,Adrian Banning,Ole Geir Solberg,Colin Berry,William F Fearon,Frederik M Zimmermann
{"title":"Takotsubo综合征微血管功能的预后价值:个体患者资料的汇总分析。","authors":"Rob Eerdekens,Mohamed El Farissi,Giovanni Luigi De Maria,Aviel Shetrit,Robert Sykes,Christina Ekenbäck,Jonas Persson,Jonas Spaak,Liam S Couch,Fernando Alfonso,Fernando Rivero,Nieves Gonzalo,Javier Escaned,Iván J Núñez Gil,Oscar Vedia Cruz,Reut Amar Shamir,Ophir Freund,Marc Vanderheyden,Marta Belmonte,Emanuele Barbato,Pim A L Tonino,Adrian Banning,Ole Geir Solberg,Colin Berry,William F Fearon,Frederik M Zimmermann","doi":"10.1016/j.jcin.2025.05.028","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nCoronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo Syndrome (TTS). However, the prognostic value of microvascular function measured in the acute phase of TTS is unclear.\r\n\r\nMETHODS\r\nIn a collaborative, pooled analysis of individual patient data from nine prospective TTS cohorts, invasive assessment of coronary microvascular function was performed, including the index of microcirculatory resistance (IMR), coronary flow reserve (CFR), and microvascular resistance reserve (MRR). The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCE) defined as the composite of all-cause death, recurrence of TTS, stroke, transient ischemic attack, or myocardial infarction.\r\n\r\nRESULTS\r\nOne hundred and sixty six patients with TTS were included, in whom 130 (78%) had the typical (apical) TTS variant and 36 (22%) an atypical variant. During a median follow-up of 20.6 [4.3 - 60.0] months, all-cause mortality occurred in 17 patients (10.2%) and MACCE in 29 patients (17.5%). IMR, CFR, and MRR were associated with all-cause mortality. After adjustment for baseline differences, IMR was the only independent predictor of both all-cause mortality (aHR 3.9; 95% CI: 1.39-10.88, P = 0.010; c-statistic 0.817 (95% CI: 0.711-0.923)) and MACCE (aHR 2.6; 95% CI: 1.17-5.67; P = 0.018; c-statistic 0.719 (95% CI: 0.612-0.826)).\r\n\r\nCONCLUSIONS\r\nIn this pooled analysis of individual patient data from nine prospective TTS cohorts, microvascular dysfunction measured in the acute phase, was associated with all-cause mortality. In particular, an elevated microvascular resistance, as assessed by IMR, was the only independent predictor of both mortality and MACCE.","PeriodicalId":14666,"journal":{"name":"JACC: Cardiovascular Interventions","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic Value of Microvascular Function in Takotsubo Syndrome: a Pooled Analysis of Individual Patient Data.\",\"authors\":\"Rob Eerdekens,Mohamed El Farissi,Giovanni Luigi De Maria,Aviel Shetrit,Robert Sykes,Christina Ekenbäck,Jonas Persson,Jonas Spaak,Liam S Couch,Fernando Alfonso,Fernando Rivero,Nieves Gonzalo,Javier Escaned,Iván J Núñez Gil,Oscar Vedia Cruz,Reut Amar Shamir,Ophir Freund,Marc Vanderheyden,Marta Belmonte,Emanuele Barbato,Pim A L Tonino,Adrian Banning,Ole Geir Solberg,Colin Berry,William F Fearon,Frederik M Zimmermann\",\"doi\":\"10.1016/j.jcin.2025.05.028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\r\\nCoronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo Syndrome (TTS). However, the prognostic value of microvascular function measured in the acute phase of TTS is unclear.\\r\\n\\r\\nMETHODS\\r\\nIn a collaborative, pooled analysis of individual patient data from nine prospective TTS cohorts, invasive assessment of coronary microvascular function was performed, including the index of microcirculatory resistance (IMR), coronary flow reserve (CFR), and microvascular resistance reserve (MRR). The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCE) defined as the composite of all-cause death, recurrence of TTS, stroke, transient ischemic attack, or myocardial infarction.\\r\\n\\r\\nRESULTS\\r\\nOne hundred and sixty six patients with TTS were included, in whom 130 (78%) had the typical (apical) TTS variant and 36 (22%) an atypical variant. During a median follow-up of 20.6 [4.3 - 60.0] months, all-cause mortality occurred in 17 patients (10.2%) and MACCE in 29 patients (17.5%). IMR, CFR, and MRR were associated with all-cause mortality. After adjustment for baseline differences, IMR was the only independent predictor of both all-cause mortality (aHR 3.9; 95% CI: 1.39-10.88, P = 0.010; c-statistic 0.817 (95% CI: 0.711-0.923)) and MACCE (aHR 2.6; 95% CI: 1.17-5.67; P = 0.018; c-statistic 0.719 (95% CI: 0.612-0.826)).\\r\\n\\r\\nCONCLUSIONS\\r\\nIn this pooled analysis of individual patient data from nine prospective TTS cohorts, microvascular dysfunction measured in the acute phase, was associated with all-cause mortality. In particular, an elevated microvascular resistance, as assessed by IMR, was the only independent predictor of both mortality and MACCE.\",\"PeriodicalId\":14666,\"journal\":{\"name\":\"JACC: Cardiovascular Interventions\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Cardiovascular Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcin.2025.05.028\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Cardiovascular Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcin.2025.05.028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prognostic Value of Microvascular Function in Takotsubo Syndrome: a Pooled Analysis of Individual Patient Data.
BACKGROUND
Coronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo Syndrome (TTS). However, the prognostic value of microvascular function measured in the acute phase of TTS is unclear.
METHODS
In a collaborative, pooled analysis of individual patient data from nine prospective TTS cohorts, invasive assessment of coronary microvascular function was performed, including the index of microcirculatory resistance (IMR), coronary flow reserve (CFR), and microvascular resistance reserve (MRR). The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCE) defined as the composite of all-cause death, recurrence of TTS, stroke, transient ischemic attack, or myocardial infarction.
RESULTS
One hundred and sixty six patients with TTS were included, in whom 130 (78%) had the typical (apical) TTS variant and 36 (22%) an atypical variant. During a median follow-up of 20.6 [4.3 - 60.0] months, all-cause mortality occurred in 17 patients (10.2%) and MACCE in 29 patients (17.5%). IMR, CFR, and MRR were associated with all-cause mortality. After adjustment for baseline differences, IMR was the only independent predictor of both all-cause mortality (aHR 3.9; 95% CI: 1.39-10.88, P = 0.010; c-statistic 0.817 (95% CI: 0.711-0.923)) and MACCE (aHR 2.6; 95% CI: 1.17-5.67; P = 0.018; c-statistic 0.719 (95% CI: 0.612-0.826)).
CONCLUSIONS
In this pooled analysis of individual patient data from nine prospective TTS cohorts, microvascular dysfunction measured in the acute phase, was associated with all-cause mortality. In particular, an elevated microvascular resistance, as assessed by IMR, was the only independent predictor of both mortality and MACCE.